Caricamento...
SAHA-induced loss of the tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model
Thyroid cancer is on the rise. Novel approaches are needed to improve the outcome of patients with recurrent and advanced metastatic thyroid cancers. FDA approval of suberoylanilide hydroxamic acid (SAHA; vorinostat), an inhibitor of histone deacetylase, for the treatment of hematologic malignancies...
Salvato in:
| Pubblicato in: | Endocr Relat Cancer |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959547/ https://ncbi.nlm.nih.gov/pubmed/27267120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0103 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|